Isoliquiritigenin suppresses human T Lymphocyte activation <i>via</i> covalently binding cysteine 46 of IκB kinase

Fenggen Yan(Guangzhou University of Chinese Medicine), Liang Liu(Fourth Hospital of Hebei Medical University)
Oncotarget
September 10, 2016
Cited by 14


Related Papers